Oracle Corporation (ORCL)
| Previous close | 87.25 |
| Open | 86.21 |
| Bid | 87.36 x 800 |
| Ask | 87.37 x 1300 |
| Day's range | 86.20 - 87.57 |
| 52-week range | 55.14 - 91.78 |
| Volume | 7,044,249 |
| Avg. volume | 10,508,834 |
| Market cap | 238.879B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 18.48 |
| EPS (TTM) | 4.72 |
| Earnings date | 08 Dec 2021 - 13 Dec 2021 |
| Forward dividend & yield | 1.28 (1.47%) |
| Ex-dividend date | 08 Oct 2021 |
| 1y target est | 83.31 |
- Yahoo Finance
Cisco CEO to Wall Street: Think of us differently
Yahoo Finance Live checks in with Cisco chairman and CEO Chuck Robbins after the company's closely watched investor day.
- PR Newswire
Adenza Chooses Oracle Autonomous Database to Expand its Multi-Cloud Risk Analytics Services
Adenza, a leading global provider of end-to-end, trading, treasury, risk management, and regulatory compliance for the financial services industry, has selected Oracle Autonomous Database—both Autonomous Transaction Processing and Autonomous Data Warehouse—to enhance its regulatory reporting product line AxiomSL's RegCloud. Adenza chose Oracle Autonomous Database for its unprecedented availability, performance, and security, each of which is critical in the regulatory industry. With Oracle Auton
- Bloomberg
DNA Startup Oxford Nanopore Wins Oracle Backing for Upcoming IPO
(Bloomberg) -- DNA-sequencing company Oxford Nanopore Technologies Ltd., whose technology is used to identify variants of Covid-19, is looking to raise 300 million pounds ($415 million), with Oracle Corp. agreeing to be a cornerstone investor.The offering will also include existing shares, the company said in a statement Thursday. The spinout from the University of Oxford supplies the U.K. with tests that use DNA and RNA sequencing to detect various strains of Covid. Its technology was also used
